Great Point Partners LLC Talaris Therapeutics, Inc. Transaction History

Great Point Partners LLC

  • $216 Million
  • Q3 2024

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2023

Nov 14, 2023
BUY
$2.68 - $3.22 $895,031 - $1.08 Million
333,967 Added 50.14%
1,000,000 $2.81 Million
Q2 2023

Aug 14, 2023
BUY
$1.78 - $3.2 $1.19 Million - $2.13 Million
666,033 New
666,033 $2.02 Million

Others Institutions Holding TALS

# of Institutions
3
Shares Held
75.7K
Call Options Held
0
Put Options Held
0
View Full List

About Talaris Therapeutics, Inc.

TALS Quotes by TradingView
  • Ticker TALS
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 39,995,900
  • Market Cap $109M
  • Description
  • Talaris Therapeutics, Inc. operates as a late-clinical stage cell therapy company in the United States. The company engages in developing a method of allogeneic hematopoietic stem cell transplantation to transform the standard of care in solid organ transplantation and severe autoimmune diseases, as well as severe non-malignant blood, immune, an...
More about TALS
Track This Portfolio

Track Great Point Partners LLC Portfolio

Follow Great Point Partners LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Great Point Partners LLC, based on Form 13F filings with the SEC.

News

Stay updated on Great Point Partners LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email